However, a systematic analyses of IL-7 serum levels in patients with liver cirrhosis and healthy individuals revealed significantly lower IL-7 serum concentrations in patients with liver cirrhosis including patients with ACLF compared to healthy controls, despite of high IFN-γ serum concentrations in patients with decompensated liver cirrhosis and ACLF [Figure 8D, detailed patient characteristics are described in (9)]. The gene discussed is IL7; the disease is cirrhosis of liver.